Patents by Inventor Akhil Maheshwari

Akhil Maheshwari has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Antithrombotic nanoparticles and methods for treating necrotizing enterocolitis
    Patent number: 11779544
    Abstract: The present disclosure is directed to antithrombotic nanoparticles and methods of treating necrotizing enterocolitis.
    Type: Grant
    Filed: March 29, 2021
    Date of Patent: October 10, 2023
    Assignee: University of South Florida
    Inventors: Akhil Maheshwari, Samuel Wickline, Kopperuncholan Namachivayam, Hua Pan
  • Antithrombotic nanoparticles and methods for treating necrotizing enterocolitis
    Patent number: 10987315
    Abstract: The present disclosure is directed to antithrombotic nanoparticles and methods of treating necrotizing enterocolitis.
    Type: Grant
    Filed: October 4, 2019
    Date of Patent: April 27, 2021
    Assignee: University of South Florida
    Inventors: Akhil Maheshwari, Samuel Wickline, Kopperuncholan Namachivayam, Hua Pan
  • Preclinical model of neonatal necrotizing enterocolitis
    Patent number: 10973932
    Abstract: The disclosure provides methods of generating a murine model of neonatal necrotizing enterocolitis, whereby the generated murine animal exhibits at least one symptom of neonatal necrotizing enterocolitis. The disclosure also provides methods to measure transfusion effects on anemia and methods for identifying and isolating an agent useful for the treatment or prevention of neonatal necrotizing enterocolitis.
    Type: Grant
    Filed: April 6, 2018
    Date of Patent: April 13, 2021
    Assignee: University of South Florida
    Inventors: Akhil Maheshwari, Mohan Kumar Krishnan
  • PRECLINICAL MODEL OF NEONATAL NECROTIZING ENTEROCOLITIS
    Publication number: 20180289841
    Abstract: The disclosure provides methods of generating a murine model of neonatal necrotizing enterocolitis, whereby the generated murine animal exhibits at least one symptom of neonatal necrotizing enterocolitis. The disclosure also provides methods to measure transfusion effects on anemia and methods for identifying and isolating an agent useful for the treatment or prevention of neonatal necrotizing enterocolitis.
    Type: Application
    Filed: April 6, 2018
    Publication date: October 11, 2018
    Applicant: University of South Florida
    Inventors: Akhil Maheshwari, Mohan Kumar Krishnan